A Roadmap to Inform Development, Validation and Approval of Digital Mobility Outcomes: The Mobilise-D Approach
Digital Biomarkers · 26.11.2020 · 4 (Suppl. 1) · 13-27
DOI: 10.1159/000512513 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Digital Biomarkers, online erschienen am 26.11.2020. Verfasst von Lynn Rochester und 17 weiteren Autor:innen. Beteiligte Einrichtung: Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom. Die Arbeit wurde bisher 155-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Mobilisation
Abstract (Originalsprache)
Health care has had to adapt rapidly to COVID-19, and this in turn has highlighted a pressing need for tools to facilitate remote visits and monitoring. Digital health technology, including body-worn devices, offers a solution using digital outcomes to measure and monitor disease status and provide outcomes meaningful to both patients and health care professionals. Remote monitoring of physical mobility is a prime example, because mobility is among the most advanced modalities that can be assessed digitally and remotely. Loss of mobility is also an important feature of many health conditions, providing a read-out of health as well as a target for intervention. Real-world, continuous digital measures of mobility (digital mobility outcomes or DMOs) provide an opportunity for novel insights into health care conditions complementing existing mobility measures. Accepted and approved DMOs are not yet widely available. The need for large collaborative efforts to tackle the critical steps to adoption is widely recognised. Mobilise-D is an example. It is a multidisciplinary consortium of 34 institutions from academia and industry funded through the European Innovative Medicines Initiative 2 Joint Undertaking. Members of Mobilise-D are collaborating to address the critical steps for DMOs to be adopted in clinical trials and ultimately health care. To achieve this, the consortium has developed a roadmap to inform the development, validation and approval of DMOs in Parkinson’s disease, multiple sclerosis, chronic obstructive pulmonary disease and recovery from proximal femoral fracture. Here we aim to describe the proposed approach and provide a high-level view of the ongoing and planned work of the Mobilise-D consortium. Ultimately, Mobilise-D aims to stimulate widespread adoption of DMOs through the provision of device agnostic software, standards and robust validation in order to bring digital outcomes from concept to use in clinical trials and health care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
- The Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
- Department of Mechanical Engineering, The University of Sheffield, Sheffield, United Kingdom.
- INSIGNEO Institute for in Silico Medicine, The University of Sheffield, Sheffield, United Kingdom.
- Translational Medicine, Novartis Institutes for Biomedical Research, Basel, Switzerland.
- Insight Centre for Data Analytics, University College Dublin, Dublin, Ireland.
Zitieren
APA
Rochester, L., Mazzà, C., Mueller, A., Caulfield, B., McCarthy, M., Becker, C., Miller, R., Piraino, P., Viceconti, M., Dartee, W. P., Garcia-Aymerich, J., Aydemir, A. A., Vereijken, B., Arnera, V., Ammour, N., Jackson, M., Hache, T., & Roubenoff, R. (2020). A Roadmap to Inform Development, Validation and Approval of Digital Mobility Outcomes: The Mobilise-D Approach. Digital Biomarkers, 4(Suppl. 1), 13-27. https://doi.org/10.1159/000512513
Vancouver
Rochester L, Mazzà C, Mueller A, Caulfield B, McCarthy M, Becker C, et al. A Roadmap to Inform Development, Validation and Approval of Digital Mobility Outcomes: The Mobilise-D Approach. Digital Biomarkers. 2020;4(Suppl. 1):13-27. doi:10.1159/000512513
BibTeX
@article{Rochester2020,
author = {Rochester, Lynn and Mazzà, Claudia and Mueller, Arne and Caulfield, Brian and McCarthy, Marie and Becker, Clemens and Miller, Ram and Piraino, Paolo and Viceconti, Marco and Dartee, Wilhelmus P and Garcia-Aymerich, Judith and Aydemir, Aida A and Vereijken, Beatrix and Arnera, Valdo and Ammour, Nadir and Jackson, Michael and Hache, Tilo and Roubenoff, Ronenn},
title = {A Roadmap to Inform Development, Validation and Approval of Digital Mobility Outcomes: The Mobilise-D Approach},
journal = {Digital Biomarkers},
year = {2020},
volume = {4},
number = {Suppl. 1},
pages = {13--27},
doi = {10.1159/000512513}
}
EUVIMED